Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia
The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA). Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively an...
Gespeichert in:
Veröffentlicht in: | CNS drugs 2007-01, Vol.21 (2), p.165-171 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 171 |
---|---|
container_issue | 2 |
container_start_page | 165 |
container_title | CNS drugs |
container_volume | 21 |
creator | ZABA, Zbigniew BIENERT, Agnieszka DROBNIK, Leon DYDERSKI, Stanislaw KUSZA, Krzysztof |
description | The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA).
Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia.
The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group.
As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values. |
doi_str_mv | 10.2165/00023210-200721020-00006 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_68985654</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A199865973</galeid><sourcerecordid>A199865973</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</originalsourceid><addsrcrecordid>eNqFkV1rFTEQhoMotlb_giyI3m1Nsvm8LMUvKHihXoc0mdTIbnJM9hT7752ec-xBECQXE948M7yTl5CB0XPOlHxLKeUTZ3TklGqsnI4oUfWInDKm7cjsJB7v7nzUVOgT8qz3H0iISamn5AR1I6jVp-T2ywbC2vw8pAY_t1DC3ZBLhF_DUktea8vlZojbXdm0uqmpzmODJScoqy95HnyJxxc_P-hrXXFqLjj8FkrddiQ99PU79OyfkyfJzx1eHOoZ-fb-3dfLj-PV5w-fLi-uxiAEW0c9qUS5iJ5raoBJiJqCkYKlYAVomrTmPnKumPBRX4eojQkWZIpJhWTZdEbe7OeiQ9yur27JPcA8-wJoySljjVRS_BfklKMZqRB8tQdv_Awul1RxwXAPuwtmrVHS6gmp839QeCJ-XagFUkb9rwazbwit9t4guU3Li293jlF3n7n7k7l7yNztMsfWlwfr2-sF4rHxEDICrw-A7wETar6E3I-ckVxarqbf3k21zA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20273656</pqid></control><display><type>article</type><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</creator><creatorcontrib>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</creatorcontrib><description>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA).
Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia.
The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group.
As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</description><identifier>ISSN: 1172-7047</identifier><identifier>EISSN: 1179-1934</identifier><identifier>DOI: 10.2165/00023210-200721020-00006</identifier><identifier>PMID: 17284097</identifier><language>eng</language><publisher>Hong Kong: Adis International</publisher><subject>Adult ; Alfentanil - administration & dosage ; Alfentanil - blood ; Anesthesia Recovery Period ; Anesthesia, Intravenous ; Anesthetics, Combined - administration & dosage ; Anesthetics, Intravenous - administration & dosage ; Anesthetics, Intravenous - blood ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Cholecystectomy, Laparoscopic ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Monitoring, Physiologic ; Neuropharmacology ; Pharmacology. Drug treatments ; Piperidines - administration & dosage ; Piperidines - blood ; Propofol - administration & dosage ; Propofol - blood ; Spectrum Analysis</subject><ispartof>CNS drugs, 2007-01, Vol.21 (2), p.165-171</ispartof><rights>2007 INIST-CNRS</rights><rights>COPYRIGHT 2007 Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</citedby><cites>FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18525926$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17284097$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZABA, Zbigniew</creatorcontrib><creatorcontrib>BIENERT, Agnieszka</creatorcontrib><creatorcontrib>DROBNIK, Leon</creatorcontrib><creatorcontrib>DYDERSKI, Stanislaw</creatorcontrib><creatorcontrib>KUSZA, Krzysztof</creatorcontrib><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><title>CNS drugs</title><addtitle>CNS Drugs</addtitle><description>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA).
Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia.
The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group.
As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</description><subject>Adult</subject><subject>Alfentanil - administration & dosage</subject><subject>Alfentanil - blood</subject><subject>Anesthesia Recovery Period</subject><subject>Anesthesia, Intravenous</subject><subject>Anesthetics, Combined - administration & dosage</subject><subject>Anesthetics, Intravenous - administration & dosage</subject><subject>Anesthetics, Intravenous - blood</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Cholecystectomy, Laparoscopic</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Physiologic</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperidines - administration & dosage</subject><subject>Piperidines - blood</subject><subject>Propofol - administration & dosage</subject><subject>Propofol - blood</subject><subject>Spectrum Analysis</subject><issn>1172-7047</issn><issn>1179-1934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV1rFTEQhoMotlb_giyI3m1Nsvm8LMUvKHihXoc0mdTIbnJM9hT7752ec-xBECQXE948M7yTl5CB0XPOlHxLKeUTZ3TklGqsnI4oUfWInDKm7cjsJB7v7nzUVOgT8qz3H0iISamn5AR1I6jVp-T2ywbC2vw8pAY_t1DC3ZBLhF_DUktea8vlZojbXdm0uqmpzmODJScoqy95HnyJxxc_P-hrXXFqLjj8FkrddiQ99PU79OyfkyfJzx1eHOoZ-fb-3dfLj-PV5w-fLi-uxiAEW0c9qUS5iJ5raoBJiJqCkYKlYAVomrTmPnKumPBRX4eojQkWZIpJhWTZdEbe7OeiQ9yur27JPcA8-wJoySljjVRS_BfklKMZqRB8tQdv_Awul1RxwXAPuwtmrVHS6gmp839QeCJ-XagFUkb9rwazbwit9t4guU3Li293jlF3n7n7k7l7yNztMsfWlwfr2-sF4rHxEDICrw-A7wETar6E3I-ckVxarqbf3k21zA</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>ZABA, Zbigniew</creator><creator>BIENERT, Agnieszka</creator><creator>DROBNIK, Leon</creator><creator>DYDERSKI, Stanislaw</creator><creator>KUSZA, Krzysztof</creator><general>Adis International</general><general>Wolters Kluwer Health, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20070101</creationdate><title>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</title><author>ZABA, Zbigniew ; BIENERT, Agnieszka ; DROBNIK, Leon ; DYDERSKI, Stanislaw ; KUSZA, Krzysztof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-736f024da2708e15ed70e8541fc94e70f772ad22614ad7bcd788c9e5fdf6cf913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Alfentanil - administration & dosage</topic><topic>Alfentanil - blood</topic><topic>Anesthesia Recovery Period</topic><topic>Anesthesia, Intravenous</topic><topic>Anesthetics, Combined - administration & dosage</topic><topic>Anesthetics, Intravenous - administration & dosage</topic><topic>Anesthetics, Intravenous - blood</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Cholecystectomy, Laparoscopic</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Physiologic</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperidines - administration & dosage</topic><topic>Piperidines - blood</topic><topic>Propofol - administration & dosage</topic><topic>Propofol - blood</topic><topic>Spectrum Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZABA, Zbigniew</creatorcontrib><creatorcontrib>BIENERT, Agnieszka</creatorcontrib><creatorcontrib>DROBNIK, Leon</creatorcontrib><creatorcontrib>DYDERSKI, Stanislaw</creatorcontrib><creatorcontrib>KUSZA, Krzysztof</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>CNS drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZABA, Zbigniew</au><au>BIENERT, Agnieszka</au><au>DROBNIK, Leon</au><au>DYDERSKI, Stanislaw</au><au>KUSZA, Krzysztof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia</atitle><jtitle>CNS drugs</jtitle><addtitle>CNS Drugs</addtitle><date>2007-01-01</date><risdate>2007</risdate><volume>21</volume><issue>2</issue><spage>165</spage><epage>171</epage><pages>165-171</pages><issn>1172-7047</issn><eissn>1179-1934</eissn><abstract>The aim of this study was to evaluate the usefulness of spectral frequency index (SFx) monitoring to assess the depth of anaesthesia during propofol-opioid total intravenous anaesthesia (TIVA).
Thirty-three patients scheduled for laparoscopic cholecystectomy under propofol TIVA were prospectively and randomly allocated to receive either remifentanil (bolus of 1.0 microg/kg, followed by continuous infusion from 0.25 to 0.05 microg/kg/min) [n = 18] or alfentanil (bolus of 10 microg/kg, followed by continuous infusion from 2.0 to 0.5 microg/kg/min) [n = 15]. EEG activity was monitored to achieve the desired depth of anaesthesia, and intravenous propofol was titrated to keep the SFx at 70-80%. The remifentanil and alfentanil groups were compared in relation to the plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia, Pearson correlation coefficient for the relationship between the plasma propofol concentration and SFx values, recovery parameters, and recall of events during anaesthesia.
The study groups were comparable with regard to demographic characteristics, type and duration of surgery, and time to resumption of spontaneous ventilation. No evidence of explicit recall was noted. The mean plasma propofol concentration required for an adequate level of hypnosis during maintenance of anaesthesia was significantly higher in the alfentanil group (3.20 microg/mL) compared with the remifentanil group (2.17 microg/L) [p < 0.05]. In both groups, the Pearson correlation coefficient test showed a linear correlation between SFx values and propofol concentration in the studied propofol concentration range. The mean time to orientation for name and place was significantly shorter (p < 0.05), the mean propofol concentration at orientation for name and place and at the resumption of spontaneous ventilation timepoints was significantly lower (both p < 0.01), and the mean SFx value at resumption of spontaneous ventilation timepoint was significantly higher (p < 0.01) in the remifentanil group.
As SFx is linearly related to plasma propofol concentration, this index may be used to measure anaesthetic effect during propofol anaesthesia. The results of this clinical trial are consistent with a previous computer-simulated opioid-propofol model with regard to intraoperative and recovery variables, although the recovery occurred at different propofol concentration and SFx values.</abstract><cop>Hong Kong</cop><cop>Auckland</cop><pub>Adis International</pub><pmid>17284097</pmid><doi>10.2165/00023210-200721020-00006</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1172-7047 |
ispartof | CNS drugs, 2007-01, Vol.21 (2), p.165-171 |
issn | 1172-7047 1179-1934 |
language | eng |
recordid | cdi_proquest_miscellaneous_68985654 |
source | MEDLINE; SpringerNature Journals |
subjects | Adult Alfentanil - administration & dosage Alfentanil - blood Anesthesia Recovery Period Anesthesia, Intravenous Anesthetics, Combined - administration & dosage Anesthetics, Intravenous - administration & dosage Anesthetics, Intravenous - blood Anesthetics. Neuromuscular blocking agents Biological and medical sciences Cholecystectomy, Laparoscopic Female Humans Male Medical sciences Middle Aged Monitoring, Physiologic Neuropharmacology Pharmacology. Drug treatments Piperidines - administration & dosage Piperidines - blood Propofol - administration & dosage Propofol - blood Spectrum Analysis |
title | Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anaesthesia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spectral%20frequency%20index%20monitoring%20during%20propofol-remifentanil%20and%20propofol-alfentanil%20total%20intravenous%20anaesthesia&rft.jtitle=CNS%20drugs&rft.au=ZABA,%20Zbigniew&rft.date=2007-01-01&rft.volume=21&rft.issue=2&rft.spage=165&rft.epage=171&rft.pages=165-171&rft.issn=1172-7047&rft.eissn=1179-1934&rft_id=info:doi/10.2165/00023210-200721020-00006&rft_dat=%3Cgale_proqu%3EA199865973%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20273656&rft_id=info:pmid/17284097&rft_galeid=A199865973&rfr_iscdi=true |